The cancer treatment technology developer's series C was led by Philips Health Technology Ventures and backed by Debiopharm and Cerner.

US-based, oncology-focused health technology developer Carevive Systems has completed an $18m series C round led by Philips Health Technology Ventures, an investment vehicle for medical device and electronics group Philips. The round included pharmaceutical company Debiopharm’s Innovation Fund, health IT equipment producer Cerner, Qure Ventures, HLM Venture Partners, LRVHealth, OurCrowd’s digital health fund and Carevive…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.